Hospitals with high mitral surgical volumes yield best M-TEER outcomes at one year: Circulation
USA: New data suggests that transcatheter Edge-to-Edge Repair (TEER) of the mitral valve for mitral regurgitation, can be safely performed in centers with low mitral valve (MV) repair volumes. However, 1-year mortality and heart failure readmission are superior at centers with higher surgical MV repair (MVr) volume.
"While there was no difference in the risk of death in the hospital or at 30 days with transcatheter edge-to-edge repair for primary mitral regurgitation when done at low-, intermediate-, and high-volume surgical centers, that equivalence didn’t hold up at one year," the researchers reported.
The findings were published online in Circulation: Cardiovascular Interventions on March 4, 2024.
Transcatheter edge-to-edge mitral valve repair is an effective treatment for patients with primary mitral regurgitation at prohibitive risk for surgical MV repair. High-volume TEER centers and high-volume MVr centers have better outcomes than low-volume centers. However, it is unknown whether MVr volume predicts TEER outcomes.
Against the above background, Paul A. Grayburn, Baylor Scott, and White Heart Hospital Plano, TX, and colleagues hypothesized that high-volume MV surgical centers would have superior risk-adjusted outcomes for TEER than low-volume centers.
To test the hypothesis, the researchers combined data from the Society of Thoracic Surgeons adult cardiac surgery database and the American College of Cardiology/Society of Thoracic Surgeons Transcatheter Valve Therapy registry.
Surgical MV repair was defined as leaflet resection or artificial chords with or without annuloplasty and was evaluated as a continuous variable and as predefined categories (<25, 25-49, and ≥50 MV repairs/year). A generalized linear mixed model assessed risk-adjusted in-hospital/30-day mortality, TEER success (mitral regurgitation ≤2+ and gradient <5 mm Hg), and 30-day heart failure readmission.
The study revealed the following findings:
- The study included 41,834 patients from 500 sites of which 66.4% were low, 20.4% intermediate, and 13.2% high-volume surgical centers.
- TEER success was 54.6% and was not statistically significantly different across MV surgical site volumes.
- TEER mortality at 30 days was 3.5%, with no significant difference across MVr volume on unadjusted or adjusted analysis of volume as a continuous variable.
- One-year mortality was 15.0% and was lower for higher MVr volume centers when adjusted for clinical and demographic variables.
- Heart failure readmission at one year was 9.4% and statistically significantly lower in high-volume centers on both unadjusted and adjusted analysis.
In conclusion, TEER can be performed safely in centers with low volumes of MV repair. However, hospitals with more surgical experience see better M-TEER outcomes in 1 year.
Reference:
Grayburn PA, Mack MJ, Manandhar P, Kosinski AS, Sannino A, Smith RL 2nd, Szerlip M, Vemulapalli S. Comparison of Transcatheter Edge-to-Edge Mitral Valve Repair for Primary Mitral Regurgitation Outcomes to Hospital Volumes of Surgical Mitral Valve Repair. Circ Cardiovasc Interv. 2024 Mar 4:e013581. doi: 10.1161/CIRCINTERVENTIONS.123.013581. Epub ahead of print. PMID: 38436084.
